Pharmacokinetic evaluation of the aripiprazole (once-monthly) injection for the treatment of bipolar disorder.

MLA

Hebbrecht, Kaat, et al. “Pharmacokinetic Evaluation of the Aripiprazole (Once-Monthly) Injection for the Treatment of Bipolar Disorder.” Expert Opinion on Drug Metabolism & Toxicology, vol. 14, no. 10, Oct. 2018, pp. 999–1005. EBSCOhost, https://doi.org/10.1080/17425255.2018.1515911.

APA

Hebbrecht, K., Morrens, M., Neels, H., Roosens, L., & Sabbe, B. G. C. (2018). Pharmacokinetic evaluation of the aripiprazole (once-monthly) injection for the treatment of bipolar disorder. Expert Opinion on Drug Metabolism & Toxicology, 14(10), 999–1005. https://doi.org/10.1080/17425255.2018.1515911

Chicago

Hebbrecht, Kaat, Manuel Morrens, Hugo Neels, Laurence Roosens, and Bernard G C Sabbe. 2018. “Pharmacokinetic Evaluation of the Aripiprazole (Once-Monthly) Injection for the Treatment of Bipolar Disorder.” Expert Opinion on Drug Metabolism & Toxicology 14 (10): 999–1005. doi:10.1080/17425255.2018.1515911.